Market Overview – In 2022, the transarterial chemoembolization (TACE) market was estimated to be worth USD 10.9 billion. The industry for transarterial chemoembolization (TACE) is expected to increase at a compound annual growth rate (CAGR) of 4.90% between 2023 and 2032, from USD 11.4 billion in 2023 to USD 16.8 billion. The Transarterial Chemoembolization (TACE) Procedure market is...